Key result
Newer cryoballoon systems like PolarX require tailored procedural techniques to optimize pulmonary vein isolation.
Why the study?
With increasing attention toward single-shot cryoballoon ablation for pulmonary vein isolation in AF, an analysis of contemporary approaches and new cryoballoon systems was needed.
This review highlights the differences between Arctic Front and PolarX cryoballoon systems and outlines procedural techniques to improve the safety and efficacy of pulmonary vein isolation in atrial fibrillation.
Operators must adapt techniques for PolarX-like devices to ensure safe PVI; leaves open standardized protocols and comparative outcome trials.
Atrial fibrillation (AF) is one of the most prevalent forms of arrhythmia, affecting approximately 1–2% of the population. Its prevalence is expected to notably increase in the coming decades due to an aging population. AF negatively impacts quality of life and cardiac function, increasing mortality risk. Catheter ablation has become a key method for treating AF, particularly for achieving pulmonary vein isolation (PVI). While traditional radiofrequency ablation remains widespread, recent years have seen increasing attention towards the single-shot cryoballoon ablation technique.This article provides an analysis of contemporary approaches to the diagnosis and cryoballoon ablation of AF, examining data on the application of new cryoballoon systems. Emphasis is placed on comparing Arctic Front and PolarX technologies, including differences in components and application methods. Various ablation approaches are described, including the direct approach, «hockey stick» method, pull-down, and pull-away techniques, focusing on their clinical efficacy and risk reduction of phrenic nerve injury.Key differences between cryoablation systems that influence clinical outcomes are investigated. The article concludes on the importance of re-evaluating skills and practices when introducing new technologies, to achieve the highest efficiency and safety in treating AF patients. Further research and continuous professional development are deemed essential for improving treatment outcomes and understanding new catheter ablation technologies.
No takes yet. Share an insight, caveat, or question.
Virstyuk et al. (2025) conducted a review in Atrial fibrillation. Cryoballoon ablation (Arctic Front and PolarX) was evaluated. New cryoballoon technologies, such as PolarX, possess distinct physical properties that require operators to adapt traditional ablation techniques to safely and effectively achieve pulmonary vein isolation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: